General Atlantic, L.P. — 13F Holdings

2026 Q3  ·  13 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, GENERAL ATLANTIC, L.P. maintained a portfolio of 13 distinct positions. The most significant new addition was KORSANA, now representing 1.76% of the total fund value. They heavily accumulated shares in RISKIFIED, increasing the position by 100.0%. The fund also reduced its exposure to PHARVARIS by 74.8%.
Position History hover any row below to update
Loading…
GENERAL ATLANTIC, L.P. New York, NY Global Growth Equity / Private Equity AUM $2,481M
PCA Score Concentration Risk
Risk ENB
Total Positions
13
Quarter
2026 Q3
Top Holding
DLO (20.4%)
Top 10 Concentration
98.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13

GENERAL ATLANTIC, L.P. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
DLO
DLOCAL
Technology 20.42% 20.86% #1 1
Prev: #2
6.0
—
-9,842,559 -21.1%
P
S
36,814,136 $506,562,511 2021 Q2 13F Filing 2026-09-30 2026-11-13
CHYM
CHIME
Technology 20.33% 14.98% #2 1
Prev: #3
6.0
—
-2,333,056 -11.0%
P
S
18,926,627 $504,205,343 2025 Q2 13F Filing 2026-09-30 2026-11-13
LFTO
LIFTOFF MOBILE
Communication Services 16.12% 20.92% #3 2
Prev: #1
6.0
—
no change no change
P
S
25,315,646 $399,987,207 2026 Q2 13F Filing 2026-09-30 2026-11-13
XP
XP, INC
Financial Services 15.20% 11.50% #4 1
Prev: #5
5.0
—
-2,607,180 -12.7%
P
S
17,958,953 $377,048,218 2019 Q4 13F Filing 2026-09-30 2026-11-13
ALKT
ALKAMI
Technology 10.69% 12.08% #5 1
Prev: #4
5.5
—
no change no change
P
S
19,379,038 $265,299,030 2021 Q2 13F Filing 2026-09-30 2026-11-13
SPTX
SEAPORT THERAPE...
Healthcare 4.96% 4.56% #6 1
Prev: #7
3.0
—
no change no change
P
S
6,101,582 $123,068,909 2026 Q2 13F Filing 2026-09-30 2026-11-13
RSKD
RISKIFIED
Technology 3.40% 0.92% #7 4
Prev: #11
4.4
—
5,324,998 100.0%
P
S
10,649,996 $84,241,468 2021 Q3 13F Filing 2026-09-30 2026-11-13
NRIX
NURIX THERAPEUT...
Healthcare 2.90% 2.53% #8
Prev: #8
2.2
—
no change no change
P
S
3,032,185 $71,893,106 2025 Q4 13F Filing 2026-09-30 2026-11-13
PHVS
PHARVARIS
Healthcare 2.11% 7.79% #9 3
Prev: #6
0.8
—
-4,899,267 -74.8%
P
S
1,651,490 $52,385,263 2021 Q1 13F Filing 2026-09-30 2026-11-13
PBLS
PARABILIS MEDIC...
Healthcare 2.00% 1.45% #10
Prev: #10
1.8
—
no change no change
P
S
1,538,461 $49,676,906 2026 Q2 13F Filing 2026-09-30 2026-11-13
KRSA
KORSANA
Healthcare 1.76% — #11
Prev: #—
4.2
—
1,366,242 —
NEW
1,366,242 $43,719,744 2026 Q3 13F Filing 2026-09-30 2026-11-13
GROV
GROVE COLLABORA...
Consumer Defensive 0.11% 0.11% #12
Prev: #12
1.0
—
no change no change
P
S
2,474,859 $2,623,351 2023 Q2 13F Filing 2026-09-30 2026-11-13
RVMD
REVOLUTION MEDI...
Healthcare 0.00% 2.31%
Sold All 😨
(Was: #9)
0.0
—
-357,791 -100.0%
CLOSED
— $— 2025 Q3 13F Filing 2026-09-30 2026-11-13
Showing 1-13 of 13 holdings

Unlock Full GENERAL ATLANTIC, L.P. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →